ANNX
SHORT CANDIDATEMeanRevComposite
20.40
Technical
0.90
Fundamental
26.90
Rank
—
Price
3.91
Hurst
0.32
As of
Sep 28, 2026
Daily
Annexon Inc
HEALTHCAREBIOTECHNOLOGYAnnexon operates as a biopharmaceutical firm in the clinical development phase, focusing on therapies targeting autoimmune and neurodegenerative conditions. The company is based in South San Francisco, California.
Market cap
$760.2M
P/E (trailing)
—
P/E (forward)
—
PEG ratio
—
Dividend yield
—
Beta
1.22
52w range
2.54 – 7.18
Return on equity
-105.30%
Profit margin
0.00%
Revenue growth
0.00%
Earnings growth
0.00%
Price history
1Y: 4.01 (+43.7%) · range 2.68–6.96
Cycle position
14/ 100 cycle scoreENTRY ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 84 · STRONG SETUP · exit proximity 0
Conviction
50/ 100 · maturity 14%
VScore.0917
Buildup.3034
EMA entry setup.3884
Fundamentals.2327
Volume profile
POC
5.45
Price vs POC
-28.4%
Overhead supply
97%
Runway
+31.9%
Value area 4.82–6.02 · 97% of 120d volume overhead · heavy supply
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| insider-activity | 0.440 | Sep 28, 2026 |
Pattern & cluster
Pattern
NEUTRAL
Cluster
NEUTRALForward returns
Not yet labeled — the study prices these as positions mature.